```html

Poznan Rash (Pruritic)

What is Poznan rash (pruritic)?

The term “Poznan rash” is most often used in Eastern‑European dermatology literature to describe a painful, red‑to‑purple, itchy (pruritic) maculopapular eruption that frequently appears on the torso, limbs, and sometimes the face. The rash is named after the city of Poznań, Poland, where a series of outbreaks were first documented in the 1990s. While the exact etiology is still a subject of investigation, clinicians recognize a characteristic pattern:

• Sudden onset of itchy, raised red bumps (papules) that may coalesce into larger patches.
• Lesions often have a “blanchable” quality—turning pale when pressed—but may become violaceous (purple‑red) if inflammation is intense.
• Symptoms are usually symmetrical, affecting both sides of the body.
• The rash can be accompanied by a burning or stinging sensation.

Because the presentation overlaps with many other skin conditions, a thorough evaluation is required to determine the underlying cause.

Common Causes

Although “Poznan rash” itself is a descriptive name, the same clinical picture can be generated by several distinct medical conditions. Below are the most frequently reported triggers:

• Viral exanthems – e.g., parvovirus B19, Epstein‑Barr virus, or adenovirus infections.
• Drug reactions – especially to antibiotics (penicillins, sulfonamides), anticonvulsants, or non‑steroidal anti‑inflammatory drugs (NSAIDs).
• Contact dermatitis – exposure to nickel, poison ivy, fragrances, or solvents.
• Atopic dermatitis flare‑ups – in individuals with a personal or family history of eczema.
• Urticarial vasculitis – an immune‑mediated small‑vessel inflammation that can leave a persistent, itchy rash.
• Scabies infestation – mites burrow into the skin, creating intensely pruritic papules.
• Tick‑borne illnesses – such as Lyme disease (erythema migrans) or rickettsial infections.
• Autoimmune connective‑tissue diseases – e.g., systemic lupus erythematosus (photosensitive rash) or dermatomyositis.
• Heat‑related eruptions – miliaria rubra ("heat rash") that can become pruritic in humid climates.
• Idiopathic pruritic papular eruption (IPPE) – a diagnosis of exclusion when no cause is found.

Associated Symptoms

Many patients notice additional signs that help narrow the diagnosis:

• Fever or chills – common with viral exanthems or systemic infections.
• Joint or muscle aches – may suggest viral illness or rheumatologic disease.
• Swelling of lymph nodes – especially cervical or axillary nodes in viral or drug reactions.
• Respiratory symptoms – cough, sore throat, or nasal congestion with certain viruses.
• Gastrointestinal upset – nausea, vomiting, or diarrhea often accompanies viral or drug‑induced rashes.
• Oral lesions – aphthous ulcers or “herald patches” in conditions like herpes simplex or erythema multiforme.
• Neurologic signs – confusion, headache, or photophobia may herald meningitis or severe infections.
• Skin changes over time – darkening (post‑inflammatory hyperpigmentation) or scarring suggests vasculitis or severe dermatitis.

When to See a Doctor

Most rashes are harmless, but certain features require prompt medical evaluation:

• Rapid spread to the face, hands, or genitals.
• Development of blisters, crusting, or oozing.
• Associated high fever (>100.4°F / 38°C) lasting more than 24 hours.
• Swelling of lips, tongue, or throat (possible anaphylaxis).
• Difficulty breathing, wheezing, or chest tightness.
• Painful joints, severe headache, or stiff neck.
• Rapidly enlarging, tender nodules or purpura (purple spots) that do not blanch.
• Rash in an immunocompromised individual (e.g., chemotherapy, HIV).

If any of these occur, seek care immediately—preferably at an urgent‑care clinic or emergency department.

Diagnosis

Diagnosing a “Poznan rash” begins with a systematic approach to rule in or out the underlying cause.

History

• Onset and progression of the rash.
• Recent medication changes, supplements, or herbal products.
• Travel history, tick exposure, or recent outdoor activities.
• Personal or family history of allergies, eczema, or autoimmune disease.
• Associated systemic symptoms (fever, joint pain, GI upset).

Physical Examination

• Distribution, morphology, and color of lesions.
• Presence of “target” lesions (suggesting erythema multiforme) or vesicles.
• Palpation for tenderness or induration.
• Examination of mucous membranes, nails, and scalp.

Laboratory & Ancillary Tests

• Complete blood count (CBC) – can reveal eosinophilia (allergic/drug reaction) or leukocytosis (infection).
• Comprehensive metabolic panel (CMP) – assesses liver/kidney function if systemic therapy is considered.
• Serologic tests – EBV, CMV, parvovirus B19 IgM/IgG, or HIV when indicated.
• Patch testing – for suspected contact dermatitis.
• Skin biopsy – 4‑mm punch biopsy examined with histology and, if needed, direct immunofluorescence (helps identify vasculitis, lupus, or drug eruptions).
• Tick-borne disease panels – Lyme IgM/IgG, RMSF PCR.
• Scraping or skin swab – for scabies or bacterial superinfection.

Treatment Options

Treatment is directed at the underlying cause and at symptom relief. Below is a tiered approach.

General Symptomatic Care

• Topical corticosteroids – low‑ to mid‑potency (hydrocortisone 1% or triamcinolone 0.1%) applied 2–3 times daily for 5–7 days.
• Oral antihistamines – second‑generation agents (cetirizine, loratadine) to reduce itching without sedation; diphenhydramine can be used at night for short‑term relief.
• Cool compresses – 10–15 minutes, several times a day, to soothe heat and erythema.
• Emollients – fragrance‑free moisturizers applied after bathing to restore skin barrier.

Specific Therapies Based on Etiology

1. Viral Exanthems

• Supportive care (rest, fluids, antipyretics such as acetaminophen).
• Acyclovir for varicella‑zoster or herpes simplex if lesions suggest these infections.

2. Drug‑Induced Rash

• Immediate discontinuation of the offending medication.
• Systemic corticosteroids (prednisone 0.5 mg/kg daily) for severe or widespread reactions, tapered over 5–10 days.

3. Contact Dermatitis

• Avoidance of the identified allergen or irritant.
• Medium‑potency topical steroids (e.g., clobetasol propionate 0.05% for 2‑week courses) for intense inflammation.

4. Atopic Dermatitis Flare

• Prescription‑strength topical steroids or calcineurin inhibitors (tacrolimus ointment).
• Dupilumab (monoclonal antibody) for moderate‑to‑severe disease that is refractory to topical therapy.

5. Scabies

• Permethrin 5% cream applied to the entire body from neck down, left on for 8‑12 hours, then washed off; repeat in 7 days.
• Oral ivermectin 200 µg/kg in two doses, 7 days apart, for resistant cases.

6. Tick‑Borne Illness

• Doxycycline 100 mg twice daily for 10‑14 days (early Lyme disease).
• Rifampin or azithromycin alternatives for patients allergic to doxycycline.

7. Vasculitis or Autoimmune Disease

• Systemic steroids (prednisone 1 mg/kg) with a slow taper.
• Immunosuppressants (azathioprine, methotrexate) or biologics (rituximab) as guided by rheumatology.

When to Escalate Care

If symptoms persist beyond 2 weeks despite appropriate therapy, if the rash spreads rapidly, or if systemic signs develop, refer to a dermatologist or appropriate specialist (infectious disease, rheumatology).

Prevention Tips

• Medication safety – keep a written list of drug allergies; inform providers before starting new meds.
• Avoid known skin irritants – use fragrance‑free soaps, wear protective clothing when handling chemicals or plants.
• Tick precautions – wear long sleeves/pants, use EPA‑registered repellents, perform daily tick checks after outdoor activities.
• Maintain skin barrier – moisturize daily, limit hot showers, and use gentle, pH‑balanced cleansers.
• Vaccination – stay up‑to‑date on influenza, COVID‑19, and other recommended vaccines to reduce viral skin manifestations.
• Prompt treatment of infections – seek care early for sore throat, fever, or other signs that could indicate a viral or bacterial infection.
• Hand hygiene – regular handwashing reduces spread of contagious viruses and bacteria that can cause rashes.

Emergency Warning Signs

---

Sources: Mayo Clinic, Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), World Health Organization (WHO), Cleveland Clinic, Journal of the American Academy of Dermatology, British Journal of Dermatology.

```